TY - JOUR
T1 - Unveiling the Neurotransmitter Symphony
T2 - Dynamic Shifts in Neurotransmitter Levels during Menstruation
AU - Kale, Mayur B.
AU - Wankhede, Nitu L.
AU - Goyanka, Barkha K.
AU - Gupta, Reena
AU - Bishoyi, Ashok Kumar
AU - Nathiya, Deepak
AU - Kaur, Parjinder
AU - Shanno, Kumari
AU - Taksande, Brijesh G.
AU - Khalid, Mohammad
AU - Upaganlawar, Aman B.
AU - Umekar, Milind J.
AU - Gulati, Monica
AU - Sachdeva, Monika
AU - Behl, Tapan
AU - Gasmi, Amin
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Society for Reproductive Investigation 2024.
PY - 2025/1
Y1 - 2025/1
N2 - The menstrual cycle is an intricate biological process governed by hormonal changes that affect different facets of a woman’s reproductive system. This review provides an overview of neurotransmitter alterations during different menstrual cycle phases and their effects on physiology and psychology. During the follicular phase, rising estrogen levels increase serotonin synthesis, enhancing mood, cognition, and pain tolerance. Estrogen may also influence dopamine levels, promoting motivation and reward sensitivity. GABA, involved in anxiety regulation, may be modulated by estrogen, inducing relaxation. Ovulation involves fluctuating dopamine and serotonin levels, potentially affecting motivation and positive mood. In the luteal phase, rising estrogen and progesterone may reduce serotonin availability, contributing to mood dysregulation, while enhanced GABAergic neurotransmission promotes sedation. Menstruation is characterized by declining estrogen and progesterone, potentially leading to mood disturbances, fluctuating GABAergic and dopaminergic neurotransmitter systems, relaxation, fatigue, motivation, and pleasure variations. Understanding neurotransmitter alterations during the menstrual cycle unveils the neurobiological mechanisms behind menstrual-related symptoms and disorders, facilitating targeted interventions. Pharmacological approaches targeting neurotransmitter systems, nutritional interventions, and lifestyle modifications show promise in managing menstrual symptoms. Future research should focus on further understanding neurotransmitter dynamics, personalized medicine, unexplored neurotransmitter roles, and integrating psychosocial factors. This knowledge will enhance well-being and quality of life for individuals experiencing menstrual-related challenges.
AB - The menstrual cycle is an intricate biological process governed by hormonal changes that affect different facets of a woman’s reproductive system. This review provides an overview of neurotransmitter alterations during different menstrual cycle phases and their effects on physiology and psychology. During the follicular phase, rising estrogen levels increase serotonin synthesis, enhancing mood, cognition, and pain tolerance. Estrogen may also influence dopamine levels, promoting motivation and reward sensitivity. GABA, involved in anxiety regulation, may be modulated by estrogen, inducing relaxation. Ovulation involves fluctuating dopamine and serotonin levels, potentially affecting motivation and positive mood. In the luteal phase, rising estrogen and progesterone may reduce serotonin availability, contributing to mood dysregulation, while enhanced GABAergic neurotransmission promotes sedation. Menstruation is characterized by declining estrogen and progesterone, potentially leading to mood disturbances, fluctuating GABAergic and dopaminergic neurotransmitter systems, relaxation, fatigue, motivation, and pleasure variations. Understanding neurotransmitter alterations during the menstrual cycle unveils the neurobiological mechanisms behind menstrual-related symptoms and disorders, facilitating targeted interventions. Pharmacological approaches targeting neurotransmitter systems, nutritional interventions, and lifestyle modifications show promise in managing menstrual symptoms. Future research should focus on further understanding neurotransmitter dynamics, personalized medicine, unexplored neurotransmitter roles, and integrating psychosocial factors. This knowledge will enhance well-being and quality of life for individuals experiencing menstrual-related challenges.
KW - Dopamine
KW - Estrogen
KW - GABA
KW - Menstrual cycle
KW - Progesterone
KW - Serotonine
UR - http://www.scopus.com/inward/record.url?scp=85210104317&partnerID=8YFLogxK
U2 - 10.1007/s43032-024-01740-3
DO - 10.1007/s43032-024-01740-3
M3 - Review article
C2 - 39562466
AN - SCOPUS:85210104317
SN - 1933-7191
VL - 32
SP - 26
EP - 40
JO - Reproductive Sciences
JF - Reproductive Sciences
IS - 1
ER -